Human Complement C3 Deficient EDTA Plasma

• Description:

  Human Complement C3 Deficient EDTA Plasma_x000D_ Catalog number: B2015124_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mL_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Plasma_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20° C_x000D_ Keywords: Complement Component 3, Complement Component III, Complement Factor 3, Complement CIII, CIII, C3, Acylation Stimulating Protein Cleavage Product, AHUS5, ARMD9, ASP, C3 and PZP like alpha 2 Macroglobulin Domain Containing Protein 1, Complement C3c alpha''_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Vercauteren KOA, Lambrecht S, Delanghe J. Preanalytical classical and alternative complement pathway activity loss Biochem Med (Zagreb). 2019 Oct 15;29(3):030701._x000D_ 2: Tati R, Kristoffersson AC, StÃ¥hl AL, Rebetz J, Wang L, Licht C, Motto D, Karpman D. Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy J Immunol. 2013 Sep 1;191(5):2184-93._x000D_ 3: Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells Kidney Int. 1994 Feb;45(2):451-60._x000D_ 4: Zilow G, Zilow EP, Burger R, Linderkamp O. Complement activation in newborn infants with early onset infection Pediatr Res. 1993 Aug;34(2):199-203._x000D_ 5: Farkas P, Csuka D, Mikes B, Sinkovits G, Réti M, Németh E, Rácz K, Madách K, Gergely M, Demeter J, Prohászka Z. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies Immunobiology. 2017 Feb;222(2):119-127._x000D_ 6: Ferrante A, Rowan-Kelly B. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni Clin Exp Immunol. 1983 Nov;54(2):477-85._x000D_ 7: Larcher VF, Wyke RJ, Vergani D, Mowat AP, Williams R. Yeast opsonisation and complement in children with liver disease. Analysis of 69 cases Pediatr Res. 1983 Apr;17(4):296-300._x000D_ 8: Rajagopalan R, Nyaundi T, Salvi VP, Rawal N. Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement Mol Immunol. 2010 Sep;47(15):2505-14._x000D_ 9: Zilow EP, Hauck W, Linderkamp O, Zilow G. Alternative pathway activation of the complement system in preterm infants with early onset infection Pediatr Res. 1997 Mar;41(3):334-9._x000D_ 10: Wei G, Yano S, Kuroiwa T, Hiromura K, Maezawa A. Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor (RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease Clin Exp Immunol. 1997 Jan;107(1):83-8. _x000D_ _x000D_ Products Related to Human Complement C3 Deficient EDTA Plasma can be found at Biofluids

• Short Description:

  Catalog Number: B2015124 (1 mL)_x000D_ Human Complement C3 Deficient EDTA Plasma is a high quality Human Complement C3 Deficient Plasma (EDTA). This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5